YOu bring up some great points; I would tend to agree with your option #3 which states "Partner unwilling to invest in global manufacturing without ownership or a sales track record (Afrezza)"

The concern is "How many times can MNKD dilute before FDA approval?" I am losing patience. My options are expiring in Jan 2013. I purchased 500 contracts jan 13 calls at strike 5 after 2nd CRL. I don't think we will make it to $5 by end of year and I am losing a lot of money.

I don't have any more money to buy at a lower cost now to bring my average down. what should be my selling strategy? any helpful tip is greatly appreciated.

thanks